pyrazines has been researched along with Leukemia, Hairy Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asch, A; Autry, MT; Balakrishna, P; Keruakous, AR; Schmidt, SA | 1 |
| Byers, J; Harvey, W; Khalaf, W; Maina, C | 1 |
2 other study(ies) available for pyrazines and Leukemia, Hairy Cell
| Article | Year |
|---|---|
Genomic profiling is a supplemental diagnostic and therapeutic modality for hairy cell leukemia variant.
Topics: Aged, 80 and over; Antineoplastic Agents; Benzamides; Female; Genomics; Humans; Leukemia, Hairy Cell; Mutation; Pyrazines | 2021 |
Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested.
Topics: Antigens, Nuclear; Antineoplastic Agents; Apoptosis; Gene Expression Regulation, Leukemic; Genes, bcl-2; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-6; Leukemia, Hairy Cell; Nuclear Proteins; Oncogenes; Proto-Oncogene Proteins c-bcl-2; Pyrazines; Quinolines; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |